Tema Neuroscience and Mental Health ETF (NASDAQ:MNTL – Get Free Report) was the recipient of a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 200 shares, a decline of 33.3% from the January 15th total of 300 shares. Based on an average trading volume of 400 shares, the days-to-cover ratio is presently 0.5 days.
Tema Neuroscience and Mental Health ETF Stock Performance
Shares of MNTL stock traded down $0.00 on Friday, hitting $25.18. 142 shares of the stock traded hands, compared to its average volume of 188. The firm’s 50-day moving average price is $25.04 and its two-hundred day moving average price is $26.01. The stock has a market capitalization of $11.08 million, a PE ratio of 25.24 and a beta of 0.99. Tema Neuroscience and Mental Health ETF has a twelve month low of $23.67 and a twelve month high of $27.66.
Tema Neuroscience and Mental Health ETF Dividend Announcement
The business also recently announced a dividend, which was paid on Thursday, December 12th. Shareholders of record on Wednesday, December 11th were given a $0.257 dividend. The ex-dividend date was Wednesday, December 11th.
About Tema Neuroscience and Mental Health ETF
The Tema Neuroscience and Mental Health ETF (MNTL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, concentrating on companies engaged in addressing disorders of the central nervous system and mental health worldwide. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
Read More
- Five stocks we like better than Tema Neuroscience and Mental Health ETF
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- How is Compound Interest Calculated?
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- Best Stocks Under $5.00
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for Tema Neuroscience and Mental Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.